PRQR   $0.9499  -2.66% Market Closed

ProQR Therapeutics NV
Total Cash 96.15M
totalCashPerShare 1.177
EBITDA -27.33M
Total Debt 19.19M
quickRatio 2.701
currentRatio 2.73
Total Revenue 15.78M
debtToEquity 58.41
Revenue/Share 0.194
ROA -0.1328
ROE -0.5039
grossProfits
freeCashflow 2.43M
operatingCashflow -34.22M
earningsGrowth
revenueGrowth 4.198
grossMargins 1.0
ebitdaMargins -1.7322301
operatingMargins -0.55719
profitMargins -1.3656399
enterpriseValue 215.45M
forwardPE -7.24
floatShares 62.82M
sharesOutstanding 103.20M
sharesShort 133.30K
sharesShortPriorMonth 158.69K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.25%
Short Ratio help_outline 0.83%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.402
Price To Book help_outline 9.00
earningsQuarterlyGrowth
netIncomeToCommon -21.54M
trailingEps -0.29%
forwardEps -0.50%
enterpriseToEbitda -7.88
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.12 3Q 2024
institutionsCount 57
lastUpdated Nov. 6, 2024, 6:26 p.m.